Varonis Systems Faces Class Action Lawsuit Over SaaS Conversion Disclosures

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Varonis Systems faces class action lawsuit alleging false statements about SaaS conversion capabilities, causing artificially inflated stock prices between February-October 2025.

Varonis Systems Faces Class Action Lawsuit Over SaaS Conversion Disclosures

A class action lawsuit has been filed against Varonis Systems, Inc., alleging the company made materially false and misleading statements regarding its ability to convert customers to its Software-as-a-Service offerings. According to the complaint, the company failed to disclose material facts that resulted in artificially inflated stock prices during the class period spanning February 4, 2025 through October 28, 2025.

The lawsuit claims that investors who purchased Varonis securities during this timeframe may have been harmed based on incomplete or inaccurate disclosures about the company's SaaS conversion performance. The allegations center on the company's ability to execute its business strategy and achieve projected customer conversion rates, which may not have been accurately communicated to the market.

Investors who suffered losses due to the alleged misstatements have until March 9, 2026 to request lead plaintiff status in the litigation. Interested parties should consult with legal counsel regarding their potential claims and the procedural requirements for participation in the class action.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 13

Related Coverage

GlobeNewswire Inc.

Plug Power Faces Class Action Over DOE Loan Claims as April Deadline Looms

Plug Power faces class action lawsuit alleging false statements about DOE loans and hydrogen facilities. Investors have until April 3, 2026 to apply as lead plaintiffs.

PLUG
GlobeNewswire Inc.

BlackRock TCP Capital Hit by Class Action Over $19B NAV Collapse

BlackRock TCP Capital faces class action lawsuit after 19% NAV decline and 12.97% stock plunge. Investors must act by April 6 deadline.

TCPC
GlobeNewswire Inc.

Corcept Therapeutics Faces Class Action Over FDA Rejection; Stock Crashed 50%

Corcept Therapeutics faces securities fraud lawsuit after FDA rejected relacorilant application. Stock plummeted 50.4% following December rejection. Investor deadline April 21, 2026.

CORT
GlobeNewswire Inc.

Class Action Lawsuit Filed Against China Liberal Education Over Alleged $300M Pump-and-Dump Scheme

Class action lawsuit filed against China Liberal Education Holdings for alleged pump-and-dump scheme coordinating with scammers, resulting in $300M+ investor losses.

CLEUF
GlobeNewswire Inc.

METC Faces Class Action Over Brook Mine Claims; Lead Plaintiff Deadline Set for March 31

Ramaco Resources faces class action lawsuit over alleged false Brook Mine operational claims, with lead plaintiff deadline set for March 31, 2026.

METCMETCBMETCI
GlobeNewswire Inc.

Disc Medicine Stock Collapses on FDA Rejection; Law Firm Probes Securities Fraud

Pomerantz LLP investigates Disc Medicine ($IRON) for potential securities fraud after FDA rejected bitopertin drug application, triggering consecutive stock declines totaling over 28%.

IRON